Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $2.35 in the prior trading day, ProKidney Corp (NASDAQ: PROK) closed at $2.21, down -5.96%. In other words, the price has decreased by -$5.96 from its previous closing price. On the day, 1.18 million shares were traded. PROK stock price reached its highest trading level at $2.35 during the session, while it also had its lowest trading level at $2.18.
Ratios:
Our goal is to gain a better understanding of PROK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.32 and its Current Ratio is at 10.32.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.Guggenheim initiated its Buy rating on September 10, 2024, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’25 when Pereira Brian JG sold 502,136 shares for $2.37 per share. The transaction valued at 1,190,062 led to the insider holds 0 shares of the business.
Pereira Brian JG sold 255,026 shares of PROK for $694,515 on Nov 12 ’25. The Director now owns 54,333 shares after completing the transaction at $2.72 per share. On Nov 12 ’25, another insider, Brian Pereira, who serves as the Director of the company, bought 675,234 shares for $2.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 664843968 and an Enterprise Value of 1390085376. For the stock, the TTM Price-to-Sale (P/S) ratio is 898.44. Its current Enterprise Value per Revenue stands at 1868.394 whereas that against EBITDA is -8.446.
Stock Price History:
The Beta on a monthly basis for PROK is 1.82, which has changed by 0.14634144 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -18.72%, while the 200-Day Moving Average is calculated to be 16.87%.
Shares Statistics:
The stock has traded on average 1.97M shares per day over the past 3-months and 1220730 shares per day over the last 10 days, according to various share statistics. A total of 135.98M shares are outstanding, with a floating share count of 103.33M. Insiders hold about 27.00% of the company’s shares, while institutions hold 28.52% stake in the company. Shares short for PROK as of 1763078400 were 13964229 with a Short Ratio of 7.08, compared to 1760486400 on 10736252. Therefore, it implies a Short% of Shares Outstanding of 13964229 and a Short% of Float of 13.569999999999999.
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of ProKidney Corp (PROK) in the stock market.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.41 and -$1.07 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.65, with 5.0 analysts recommending between -$0.42 and -$1.2.
